HCV Disease Progression
Coverage of the 2013 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Wednesday, 30 October 2013 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2013) in Washington, DC, November 1-5, 2013.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
10/30/13
Coffee and Chocolate May Reduce Liver Inflammation in HIV/HCV Coinfected People
- Details
- Category: HCV Disease Progression
- Published on Friday, 27 September 2013 00:00
- Written by Liz Highleyman
HIV/HCV coinfected individuals who drank more coffee and ate more chocolate had lower levels of alanine aminotransferase, an enzyme marker for liver inflammation, according to a study described in the August 26 online edition of the Journal of Hepatology.
IAS 2013: FibroScan Predicts Liver Decompensation and Death Among HIV/HCV Coinfected People
- Details
- Category: HCV Disease Progression
- Published on Monday, 08 July 2013 00:00
- Written by Liz Highleyman
The non-invasive transient elastometry method of estimating liver damage may be a better way to predict which people coinfected with HIV and hepatitis C will progress to decompensated liver cirrhosis and death, researchers reported last week at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013).
Sex, Genotype, and IL28B Pattern Predict Spontaneous HCV Clearance
- Details
- Category: Acute Hepatitis C
- Published on Wednesday, 14 August 2013 00:00
- Written by Liz Highleyman
Women, people with hepatitis C virus (HCV) genotype 1, and those with a favorable IL28B gene pattern are more likely to spontaneously clear HCV without treatment, while those with unfavorable patterns are more likely to benefit from earlier therapy, according to 2 recent studies.
EASL 2013: HIV/HCV Coinfected Patients More Likely to Develop Cirrhosis, but Treatment Lowers Risk
- Details
- Category: HCV Disease Progression
- Published on Thursday, 30 May 2013 00:00
- Written by Liz Highleyman
Sustained response to hepatitis C treatment leads to slow regression of liver fibrosis in people with HIV/HCV coinfection, but they remain at elevated risk for liver cirrhosis compared to those without HCV, researchers reported at the EASL International Liver Congress (EASL 2013) last month in Amsterdam.
More Articles...
- EASL 2013: Probiotics May Help Manage Hepatic Encephalopathy in Patients with Cirrhosis
- Liver Cancer Increasing among People with HIV/HCV Coinfection
- Hepatitis C Re-treatment with Interferon Monotherapy Provides Little Benefit
- HIV+ People Who Get Hepatitis C May Experience Rapid Liver Disease Progression
Web Design and Development by